Intensive glucose therapy improves some markers

04/25/2013 | Healio

Older type 2 diabetes patients who underwent intensive glucose-lowering therapy attained better adiponectin, lipid and triglyceride levels at nine months, a study indicated. However, the intensive therapy did not appear to improve cardiovascular outcomes in patients, researchers reported in Diabetes Care.

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC
Director of Claims
Meridian Health Plan
Detroit, MI
Sr. Analyst-Healthcare
BJC HealthCare
Saint Louis, MO
Regulatory Senior Managing/Principal Engineer/Scientist
Exponent
Menlo Park, CA